Bupivacaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Kindos Pharmaceuticals Co. Ltd. with status To Be Discontinued. The shortage was first posted on 05/05/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Kindos Pharmaceuticals Co. Ltd.
- Package NDC
- 71288-722-32
- Dosage Form
- Injection
- Presentation
- Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)
- Initial Posting
- 05/05/2026
- Revised Date